Promoter holding
64.27%
RS
Reconstructive Surgery India - Due diligence report
A 360° intelligence report on Reconstructive Surgery India: trust score, financial health, credit view, compliance, directors, growth and di…
RS
Reconstructive Surgery India
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Reconstructive Surgery India — 360° Intelligence Report
Generated from MCA filings & public records48/100
Trust Score
Caution Indicated
Reconstructive Surgery India is assessed as Caution Indicated with a Trust Score of 48/100. Reconstructive Surgery India is a private not for profit company incorporated in 2012, operating in the Healthcare sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.
Report generated on 16 Jul 2026 from the latest processed filings. Reconstructive Surgery India snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreCaution Indicated
48/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 1 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- No open charges - unencumbered balance sheet.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 30/100 Caution Indicated
- Company status is "Dissolved Under Section 59(8)" - not Active.
- Last balance sheet is for Mar 2023 - filings overdue.
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SHAILESH BAHETI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GEETA VORA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUJATA MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DEEKSHA GEHLOT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Resurge International
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Resurge International | Holding Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 14+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Dissolved Under Section 59(8).
Compliance score is weak (30/100).
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence43/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment31/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view16/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 14 events21 Oct 2023
Director appointed
SHAILESH BAHETI (IRP/RP/Liquidator)
07 Jul 2023
Last AGM held
Annual general meeting
31 Mar 2023
Latest balance sheet
Filed with ROC
04 Sep 2019
Director ceased
DEEKSHA GEHLOT
15 Dec 2018
Director appointed
DEEKSHA GEHLOT (Director)
22 Sep 2016
Director ceased
ABHISHEK JAIN
Director ceased
VIVEK SINHA
07 Jul 2015
Director ceased
SUJATA MEHTA
07 May 2015
Director appointed
SUJATA MEHTA (Director)
01 Dec 2014
Director ceased
JAYAKRISHNAN BHAKTAVATSALA
14 Aug 2014
Director appointed
GEETA VORA (Director)
Director ceased
PANKAJ JAIN
05 Mar 2014
Director ceased
MANOJ GOPALAKRISHNA
29 Mar 2012
Incorporated
Registered with Roc Hyderabad
10
Key Observations
Auto-generated from the data above4 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
| Company | CIN | Location |
|---|---|---|
| Engikart Labs India Private Limited | U74999PN2016PTC165532 | Pune, Maharashtra, India |
| Preethika Healthcare Private Limited | U85110TG2011PTC073240 | Hyderabad, Andhra Pradesh, India |
| Rizm Laboratories Private Limited | U24200MH2015PTC270548 | Nagpur, Maharashtra, India |
| Sitala Care Private Limited | U85100WB2013PTC193130 | Kolkata, West Bengal, India |
| Kumar Ramanand Medicare Private Limited | U74900BR2010PTC015409 | Desari, Bihar, India |
| Gen Health-Aid Technologies Private Limited | U24233DL2008PTC178560 | Delhi, Delhi, India |
| Masang Laboratories Private Limited | U74900KA2016PTC086025 | Bangalore, Karnataka, India |
| Dicom Grid Medical Imaging Private Limited | U74999TN2015PTC102208 | Chennai, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Reconstructive Surgery India before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Reconstructive Surgery India: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Reconstructive Surgery India - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 48/100, distress signals and MSME payment-delay disclosures - know whether Reconstructive Surgery India pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Reconstructive Surgery India - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Reconstructive Surgery India an active company?
Reconstructive Surgery India has MCA status “Dissolved Under Section 59(8)” with a compliance score of 30/100 (Caution Indicated).
Is Reconstructive Surgery India financially healthy?
Reconstructive Surgery India has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Reconstructive Surgery India?
Its overall Trust Score is 48/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Reconstructive Surgery India?
The ultimate holding entity is Resurge International. 4 active director(s) are on record.
Does Reconstructive Surgery India have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Reconstructive Surgery India up to date with its ROC filings?
Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).
Is it risky to lend to Reconstructive Surgery India?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
